The purpose of this study is to use a program called Regulating Together (RT), a remote,
non-pharmacologic intervention to treat symptoms of emotion dysregulation in children and
adolescents with Tuberous Sclerosis Complex (TSC) and TSC-Associated Neuropsychiatric
Disorder (TAND).
Recruitment Criteria
Accepts Healthy Volunteers
Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms
No
Study Type
An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.
An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.
Searching Both is inclusive of interventional and observational studies.
Interventional
Eligible Ages
8 Years - 17 Years
Gender
All
More Inclusion & Exclusion Criteria
Inclusion Criteria:
- Children ages 8-17 years inclusive with a documented clinical and/or genetic
diagnosis of TSC and exhibiting symptoms of behavioral dysregulation (identified on
the TAND Checklist having temper tantrums, aggressive outbursts, self-injury, and/or
impulsivity) are eligible for inclusion.
- Participants and their caregivers have access to a computer, phone, or tablet with
video capability and stable internet connection.
If lack of a device or internet
service is the sole barrier to eligibility/participation, interested individuals
will be connected to a TSC Clinic social worker to link them to existing government
and charity programs specifically addressing this disparity in underserved
communities and households in need (e.g., the Affordable Connectivity Program).
- Participants must also be willing to participate in treatment sessions and have
minimal levels of functional verbal communication (child and their caregiver must be
fluent in English.
- Child must have a minimum IQ>65 on the WASI-II at the screening/baseline visit).
Exclusion Criteria:
- Participants be on a stable medication regimen at least 4 weeks prior to enrollment.
- Do not have a plan to start a new psychosocial intervention (e.g., individual
psychotherapy, family psychotherapy, group psychotherapy or social skills training)
or behavior medication within 30 days prior to enrollment or at any point during the
study.
----Participants with significant disruptive, aggressive, self-injurious or
sexually inappropriate behaviors deemed potentially dangerous or overly disruptive
to the group dynamic/session, having significant co-occurring neuropsychiatric
illness warranting other treatment approaches as determined by study clinician
(e.g., substance use disorders, psychotic disorders, schizophrenia), or having
significant sensory impairment that would limit participation in intervention
curriculum/materials (e.g., blindness or uncorrected hearing loss) also will be
excluded.
Trial Details
Trial ID:
This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.
Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.
Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.
Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.
Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.
N/A
Lead Sponsor
The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.
University of Rochester
Principal Investigator
The person who is responsible for the scientific and technical direction of the entire clinical study.
Jamie Capal, MD
Principal Investigator Affiliation
University of North Carollina at Chapel Hill
Agency Class
Category of organization(s) involved as sponsor (and collaborator) supporting the trial.
Other, U.S. Fed
Overall Status
Recruiting
Countries
United States
Conditions
The disease, disorder, syndrome, illness, or injury that is being studied.
TSC, Behavioral Symptoms
Additional Details
This is a non-pharmacological intervention that will utilize small group-based therapy
with participants, followed by a separate caregiver session. The clinical trial will
consist of four phases; 1) single in person screening/baseline visit; 2) RT control phase
which is a 5-week observational period (Week 1-5); 3) RT intensive phase which is a
remote group treatment intervention twice per week over 5 weeks (Week 6-10); 4) RT
individualization phase, which is an individualized consultation with the participant and
caregiver (Week 11); and 5) the RT generalization phase which is a 10 week follow up
period consisting of utilizing the learned skills at home. At the end of the 10-week
generalization phase, a semi-structured interview for thematic analysis will occur at the
end of the study to capture facilitators and barriers to the intervention (Week 12-22).
Arms & Interventions
Arms
Experimental: Parents
In this 22-week almost completely remote study, following a 5-week control phase, parents
will receive intensive treatment twice per week for 5 weeks followed by a one-time,
1-on-1 counseling session with an RT psychologist (week 11). Then, parents will use skill
practice and application in the home environment for 10 weeks. Following this, a final
interview is conducted (week 22).
Experimental: Children
In this 22-week almost completely remote study, following a 5-week control phase,
children will receive intensive group treatment, twice a week for 5 weeks delivered
remotely. During the children's sessions, they will use child structured videos, the
PlayPosit curriculum and learning rewards. The following assessments will be completed by
the parents, regarding their children, at each phase; EDI, ABC-2, FS, BRIEF-2, CRS,
PSI-4SF and CGI-I. Following the completion of group treatment, there will be a one-time,
1-on-1 counseling session with an RT psychologist.
Interventions
Behavioral: - Behavioral Intervention in a small group platform
RT is small-group-based, intensive behavioral intervention session delivered twice weekly
over a secure remote platform for 60-minutes over 5 weeks. Each session is led by a
psychologist trained and certified in RT. Caregiver groups meet at the same frequency and
duration but at different times. Each session has a specific focus for teaching
participants to identify emotions and incorporation of cognitive behavioral therapy (CBT)
and mindfulness skills that are reinforced through repeated practice. Each session will
include a review, relaxation, new material didactic, activities to reinforce material,
mindfulness, and homework.
Contact a Trial Team
If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.
Carrboro, North Carolina
Status
Completed
Address
University of North Carolina Chapel Hill-Carolina Institute for Developmental Disabilities
This website uses cookies to improve your user experience. By using this site you agree to our use of cookies. Please read our Privacy Policy to learn more.
Ok